Sign Up Today and Learn More About Eureka Therapeutics Stock
Invest in or calculate the value of your shares in Eureka Therapeutics or other pre-IPO companies through EquityZen's platform.
Eureka Therapeutics Stock (EUTH)
Eureka Therapeutics is a biotechnology company focuses on an immunotherapies for the treatment of cancer.
About Eureka Therapeutics Stock
Founded
2006
Headquarters
Emeryville, CA, US
Total Funding
83.9M
Industries
Messaging and Telecommunications, Content and Publishing, Sports
Eureka Therapeutics pursues innovations that will change the world. We develop technologies that advance the field of antibody therapeutics by increasing the efficacy and specificity of antibody drugs, and the expression level of antibody cell lines. Eureka also provides a wide array of contract research services available to other companies. These services center around cell line development and antibody production or purification.
Eureka Therapeutics Press Mentions
Stay in the know about the latest news on Eureka Therapeutics
Trends & Strategies Shaping the Hepatoblastoma Treatment Market, 2025-2030: Includes Shares by Drug Class, Treatment, End User, Region and Company
globenewswire • Apr 04, 2025
Global Advanced Liver Cancer Market Outlook 2025-2034: Growth Drivers, Share, And Trends
einpresswire • Feb 19, 2025
Cells expressing chimeric activating receptors and chimeric stimulating …
patents • Feb 08, 2025
Compositions targeting gpc2 and gpc3 and their use for treating solid tumors
patents • Feb 08, 2025
Constructs Targeting AFP Peptide/MHC Complexes And Uses Thereof
patents • Feb 08, 2025
Eureka Therapeutics Management
Leadership team at Eureka Therapeutics
Research Scientist
Shon Green
Founder, CEO
Cheng Liu
Join now and verify your accreditation status to gain access to:
- Eureka Therapeutics Current Valuation
- Eureka Therapeutics Stock Price
- Eureka Therapeutics Management
- Available deals in Eureka Therapeutics and all other companies with relevant Deal Offering documents
- EquityZen's proprietary data and insights, which may include
- Eureka Therapeutics Cap Table and Funding History by Share Class and Liquidity Preferences
- Eureka Therapeutics Revenue and Financials
- Eureka Therapeutics Highlights
- Eureka Therapeutics Business Model
- Eureka Therapeutics Risk Factors
- Eureka Therapeutics Research Report from SACRA Research
Trading Eureka Therapeutics Stock
How to invest in Eureka Therapeutics stock?
Accredited investors can buy pre-IPO stock in companies like Eureka Therapeutics through EquityZen funds. These investments are made available by existing Eureka Therapeutics shareholders who sell their shares on our platform. Typically, these are early employees who need to fund a life event – house, education, etc. Accredited investors are then offered the opportunity to invest in this stock through a fund, like those used by hedge funds serving large investors. While not without risk, investing in private companies can help investors reach goals of portfolio diversification, access to potential growth and high potential return. Learn more about our Guided Investment process here.
How to sell Eureka Therapeutics stock?
Shareholders can sell their Eureka Therapeutics stock through EquityZen's private company marketplace. EquityZen's network includes over 360K accredited investors interested in buying private company stock. Learn more about the easy and guided Shareholder process here.
If I invest, how do I exit my investment?
There are two ways to exit your private company investment on EquityZen's marketplace. The first is if the company has an exit event like an IPO, merger or acquisition. In that case, we will distribute the shares and/or cash to you directly. The second way is through an Express Deal on EquityZen, if eligible. An Express Deal allows you to sell your allocation of private shares in a given private company to another investor on EquityZen's marketplace. More information on Express Deals can be found here and exit information can be found here.
Why choose EquityZen?
Since 2013, the EquityZen marketplace has made it easy to buy and sell shares in private companies. EquityZen brings together investors and shareholders, providing liquidity to early shareholders and private market access to accredited investors. With low investment minimums through our funds and with more than 46K private placements completed across 450+ companies, EquityZen leads the way in delivering "Private Markets for the Public."
